Exon-skipping therapies show promise for Duchenne muscular dystrophy
At the 2014 AAN Annual Meeting, investigators reported promising new data from two separate trials of exon-skipping therapies for Duchenne muscular dystrophy (DMD), eteplirsen and drisapersen.